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ABSTRACT 
Background. Previous state-of-the-art systems on Drug Name Recognition (DNR) and 
Clinical Concept Extraction (CCE) have focused on a combination of text “feature 
engineering” and conventional machine learning algorithms such as conditional random 
fields and support vector machines. However, developing good features is inherently heavily 
time-consuming. Conversely, more modern machine learning approaches such as recurrent 
neural networks (RNNs) have proved capable of automatically learning effective features 
from either random assignments or automated word “embeddings”.  
Objectives. (i) To create a highly accurate DNR and CCE system that avoids conventional, 
time-consuming feature engineering. (ii) To create richer, more specialized word embeddings 
by using health domain datasets such as MIMIC-III. (iii) To evaluate our systems over three 
contemporary datasets. 
Methods. Two deep learning methods, namely the Bidirectional LSTM and the Bidirectional 
LSTM-CRF, are evaluated. A CRF model is set as the baseline to compare the deep learning 
systems to a traditional machine learning approach. The same features are used for all the 
models. 
Results. We have obtained the best results with the Bidirectional LSTM-CRF model, which 
has outperformed all previously proposed systems. The specialized embeddings have helped 
to cover unusual words in DDI-DrugBank and DDI-MedLine, but not in the 2010 i2b2/VA 
IRB Revision dataset. 
Conclusions. We present a state-of-the-art system for DNR and CCE. Automated word 
embeddings has allowed us to avoid costly feature engineering and achieve higher accuracy. 
Nevertheless, the embeddings need to be retrained over datasets that are adequate for the 
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In recent years, the amount of digital information generated from all sectors of society has 
increased rapidly, and as a result, agriculture, industry, small businesses and, of course, 
healthcare, are becoming more efficient and productive thanks to the insights obtained from 
the “Big Data”. However, in order to deal effectively with such large data, there is an 
ongoing need for novel, scalable and more accurate analytic tools. 
In the healthcare system, patients’ medical records represent a big data source. Even 
though the records contain very useful information about the patients, in most cases the 
information consists of unstructured text such as, among others, doctors’ notes, medical 
observations made by various physicians, and descriptions of the recommended treatments. 
This type of data cannot be analyzed using common statistical tools; rather, they need to be 
approached by Natural Language Processing (NLP) techniques. In this paper, we focus on a 
well-known task in NLP, namely Named-Entity Recognition (NER). The goal of NER is to 
automatically find “named entities” in text and classify them into predefined categories such 
as people, locations, companies, time expressions etc. In the case of specialized domains, 
NER systems focus on text with specific dictionaries and topics, together with dedicated sets 
of named-entities. In the health domain, the two most important NER tasks are Clinical 
Concept Extraction (CCE) and Drug Name Recognition (DNR). The former aims to identify 
mentions of clinical concepts in patients’ records to help improve the organization and 
management of healthcare services.  Named entities in CCE can include test names, 
treatments, problems related to individual patients, and so forth. The latter seeks to find drug 
mentions in unstructured biomedical texts to match drug names with their effects and 
discover drug-drug interactions (DDIs). DNR is a key step of pharmacovigilance (PV) which 
is concerned with the detection and understanding of adverse effects of drugs and other drug-
related problems. Figure 1 shows examples of both tasks. 
 
 
Figure 1. (a) DNR and (b) CCE tasks examples, where ‘B’ (beginning) specifies the start of a named entity, ‘I’ (inside) 
specifies that the word is part of the same named entity, and ‘O’ (outside) specifies that the word is not part of any 
predefined class 
 
  NER is a challenging learning problem because in most domains the training datasets are 
scarce, preventing a “brute-force” approach by exhaustive dictionaries. Consequently, many 
systems rely on hand-crafted rules and language-specific knowledge to solve this task. To 
give a simple example of such rules, if the word begins with a capital letter in the middle of 
the sentence, it can be assumed to be a named entity in most cases. Nevertheless, these 
approaches are time-costly to develop, depend considerably on the language and the domain, 
are ineffective in the presence of informal sentences and abbreviations and, although they 
usually achieve high precision, suffer from low recall (i.e., they miss many entities). 
Conversely, machine learning (ML) approaches overcome all these limitations as they are 
intrinsically robust to variations. Current state-of-the-art ML methods follow a two-step 
process: 1) feature engineering and 2) automated classification.1-4 The first step represents the 
text by numeric vectors using domain-specific knowledge. The second step refers to the task 
of classifying each word into a different named-entity class, with popular choices for the 
classifier being the linear-chain Conditional Random Fields (CRF), Structural Support Vector 
Machines (S-SVM) and maximum-entropy classifiers. The drawback of this approach is that 
feature engineering can be often as time-consuming as the manual design of rules.  
In recent years, the advent of deep learning has contributed to significantly overcome this 
problem.5,6,7 The Long Short-Term Memory (LSTM) and its variants (e.g., the Bidirectional 
LSTM), which are a specific type of Recurrent Neural Networks (RNNs), have reported very 
 
promising results.5 In these models, words only need to be assigned to random vectors, and 
during training the neural network is able to automatically learn improved representations for 
them, completely bypassing feature engineering. In order to further increase the performance 
of these systems, the input vectors can alternatively be assigned with general-purpose word 
embeddings learned with GloVe or Word2vec.8-9 The aim of general-purpose word 
embeddings is to map every word in a dictionary to a numerical vector (the embedding) so 
that the distance between the vectors somehow reflects the semantic difference between the 
words. For example, ‘cat’ and ‘dog’ should be closer in the vector space than ‘cat’ and ‘car’. 
The common principle behind embedding approaches is that the meaning of a word is 
conveyed by the words it is used with (its surrounding words, or context). Therefore, the 
training of the word embeddings only requires large, general-purpose text corpora such as 
Wikipedia (400K unique words) or Common Crawl (2.2M unique words), without the need 
for any manual annotation. However, drug and clinical concept recognition are very domain-
specific tasks, and many words might not appear in general-domain datasets. In order to 
assign word embeddings to these specialized words, the embedding algorithms need to be 
retrained using medical domain resources such as the MIMIC-III corpora.10 As well as 
semantic word embeddings, character-level embeddings of words can also be automatically 
learned. Such embeddings can capture typical prefixes and suffixes, providing the classifiers 
with richer representations of the words.5  
Preliminary results for the work presented in this paper have obtained very promising 
accuracy in DNR and CCE tasks using neural networks. Chalapathy et al.11 presented a DNR 
system that uses a Bidirectional LSTM-CRF architecture with random assignments of the 
input word vectors at the EMNLP 2016 Health Text Mining and Information Analysis 
workshop. The reported results were very close to the system that ranked first in the 
SemEval-2013 Task 9.1. In Chalapathy et al.12, the authors leveraged the same architecture 
 
for CCE at the Clinical NLP 2016 workshop, this time using pre-trained word embeddings 
from GloVe, and the results outperformed previous systems over the 2010 i2b2/VA IRB 
Review dataset. In this paper, we extend the previous research by training the deep networks 
with more complex and specialized word embeddings. Moreover, we explore the impact of 
augmenting the word embeddings with conventional feature engineering. As methods, we 
compare contemporary recurrent neural networks such as the Bidirectional LSTM and the 
Bidirectional LSTM-CRF against a conventional ML baseline (a CRF). We report state-of-
the-art results in both DNR and CCE. 
 
II. RELATED WORK 
Most of the research carried out in domain-specific NER has combined supervised and 
semi-supervised ML models with text feature engineering. For example, the WBI-NER 
system that ranked first in the SemEval-2013 Task 9.1 (Recognition and classification of 
pharmacological substances, DNR),3 is based on a linear-chain CRF with specialized 
features. Other similar systems for DNR2,13 use various general- and domain-specific features. 
In CCE, the same approach (feature engineering + conventional ML classifier) has achieved 
the best results.4,14 
In the recent years, there has been an increase in the use of deep neural networks for a 
variety of NLP tasks, including NER.5,6,7 Pre-trained word embeddings 8,9,15 have been used 
in traditional ML methods 16, 17 and in neural networks, where Deconourt et al.18 has achieved 
better performance than previously published systems in de-identification of patient notes. 
Cocos et al.19 have used the Bidirectional LSTM model for labelling Adverse Drug Reactions 
in pharmacovigilance. Xie et al.20 have used a similar model for studying the adverse effects 
of e-cigarettes. Wei et al.21 have combined the output of a Bidirectional LSTM and a CRF as 
input to an SVM classifier for disease name recognition. A possible drawback of this 
 
approach is that the overall prediction is not structured and may miss on useful correlation 
between the output variables. 
In a work that is more related to ours, Jaganatha & Yu 22 have employed a Bidirectional 
LSTM-CRF to label named entities from electronic health records of cancer patients. Their 
model differs in the CRF output module where the pairwise potentials are modelled using a 
Convolutional Neural Network (CNN) rather than the usual transition matrix. Gridach has 
also used the Bidirectional LSTM-CRF for named-entity recognition in the biomedical 
domain. 
The main difference and contribution of the proposed approach is that it leverages 
specialized health-domain embeddings created from a structured database. In the 
experiments, these embeddings have been used jointly with general-domain embeddings and 
they have proved able to improve the accuracy in several cases. In addition, our work 
evaluates the use of hand-crafted features, both in isolation and alongside the automated word 
embeddings. This aims to provide a comprehensive feature comparison for health-domain 
named-entity recognition based on LSTM models.  
III. METHODS 
In this section we provide a description of the main methods employed. First, we describe 
the conditional random field (CRF), a traditional machine learning approach for the 
classification of sequences which is used as a baseline in the experiments. This baseline is 
compared with two variants of a contemporary recurrent neural network which are known as 
Bidirectional LSTM and Bidirectional LSTM-CRF, respectively. 
 
A.  CRF 
A CRF model is a well-known machine learning approach that has been widely used in 
NER.25 It predicts sequences of labels () from sequences of measurements () taking into 
 
account the sequentiality of the data. (R1.1) A CRF model, |, 	
, is given in equation 
(1) below, where 	 notes the model’s parameters, Ѱ, 
 is the chosen features vector and 
	, 
 is the cumulative sum of |, 	
 over all the possible : 
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The parameters of this model are typically learned from a training set, , 
 =
, ,  = 1 … , with conditional maximum likelihood as in: 
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 !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 (2) 
Once the model has been trained, the prediction of a CRF is the sequence of labels 
maximizing the model for the given the input sequence and the learned parameters: 
 
 =  !"

  |, 	
 (3) 
 
The labels are typically predicted using a Viterbi-style algorithm which provides the 
optimal prediction for the measurement sequence as a whole. The model is trained by 
maximizing the conditional likelihood, or cross-entropy, over a given training set. For its 
implementation, we have used the HCRF library.26 The features used as input are described in 
Section IV. In the experiments, we use the CRF as a useful baseline for performance 
comparison with the proposed neural networks. Note that a CRF model is also used as the 
output layer in the Bidirectional LSTM-CRF as explained in the next section. 
 
B.  Bidirectional LSTM and Bidirectional LSTM-CRF 
RNNs are a type of neural network architecture in which connections between units form a 
directed cycle, creating an internal state and achieving dynamic temporal behavior. Thanks to 
their internal memory, RNNs can process a sequence of vectors ("#, "$,..., "%) as input and 
 
produce another sequence (ℎ#, ℎ$,..., ℎ%) as output that contains some extent of sequential 
information about every vector in the input. However, these architectures in practice fail to 
learn long-term dependencies in the sequences as they tend to be biased by the most recent 
vectors.27 The Long Short-Term Memory (LSTM) was therefore designed to overcome this 
issue by incorporating a gated memory-cell that has been shown to capture long-term 
dependencies.28 Equation (4) shows the implementations of the different gates in the LSTM,5 
where ' is the “input” gate, (' is the “cell” gate, )' is the “output” gate, * are the weights of 
the network, + are the biases, , is the element-wise sigmoid function, and ʘ is the element-
wise product.  The bidirectional LSTM is just a variation, in which both the left-to-right (ℎ) 
and the right-to-left (ℎ.) representations of the input sentence are generated, and then 
concatenated ℎ = [ℎ ; ℎ.] in order to obtain the final representation. 
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When applying the LSTM in NER, the words in the input sentence are first mapped to 
numerical vectors. These vectors can be random valued, a pre-trained word embedding, 
domain-specific word features or any combination of them. For each vector, the output of the 
network are the posterior probabilities of each named-entity class. An improvement of these 
networks has been presented by Lample et al.5 using a CRF as a final output layer. This final 
layer provides the system with the ability to perform joint decoding of the input sequence in 
a Viterbi-style manner. The resulting network is known as the Bidirectional LSTM-CRF. We 
test the LSTM models with the same features used for the CRF in order to establish the 
 
fairest-possible comparison. The features are described in detail in Section IV. Figure 2 
shows a descriptive diagram of the Bidirectional LSTM-CRF. 
 
Figure 2. The bidirectional LSTM-CRF with word-level and character-level word embeddings. In the example, word 
‘sulfate’ is assumed to be the 5th word in a sentence and its only entity;‘x5’ represents its word-level embedding (a single 
embedding for the whole word); ‘x5*’ represents its character-level embedding, formed from the concatenation of the last 
hidden state of the forward and backward passes of a character-level LSTM; ‘h1-5’ are the hidden states of the main LSTM 
which become the inputs into a final CRF; eventually, the CRF provides the predicted labeling. 
IV. WORD FEATURES 
As mentioned above, neural networks can learn meaningful representations from random 
assignments of word embeddings. However, it has been proved that pre-trained word 
embeddings can improve the performance of the network.5,11,18,24 In this section, we present 
the pre-trained embeddings employed in lieu of the random assignments.  
 
A. Specialized Word Embeddings 
A word embedding maps a word to a numerical vector in a vector space, where 
semantically-similar words are expected to be assigned similar vectors. To perform this 
mapping, we have used a well-known algorithm called GloVe.8 This algorithm learns word 
embeddings by looking at the co-occurrences of the word in the training data, assuming that a 
 
word’s meaning is mostly defined by its context and, therefore, words having similar contexts 
should have similar embeddings. GloVe can be trained from large, general-purpose datasets 
such as Wikipedia, Gigaword5 or Common Crawl without the need for any manual 
supervision. In this work, we have experimented with different general-purpose, pre-trained 
word embeddings from the official GloVe website 29 and noticed that the embeddings trained 
with Common Crawl (cc) (2.2M unique words) were giving the best results. We have 
employed these embeddings on their own, and also concatenated with the MIMIC-III 
embeddings (cc/mimic). By default, the code initializes the word embedding of each unique 
word in the dictionary with a unique random vector. In alternative, we replace the random 
initialization with a pre-trained embedding. However, athough such datasets generate good 
embeddings in many cases, for domain-specific tasks such as DNR and CCE they can suffer 
from some lack of vocabulary. As a matter of fact, in health corpora it is common to find very 
technical and unusual words which are specific to the health domain. If GloVe is trained only 
with general-purpose datasets, it is likely that such words will be missing and will still have 
to be assigned with random vectors. 
In order to solve this problem, we have generated a new word embedding by re-training 
GloVe with a large health domain dataset called MIMIC-III.10 This dataset contains records 
of 53,423 distinct hospital admissions of adults to an intensive care unit between 2001 and 
2012. The data, structured in 26 tables, include information such as vital signs, observations 
of care providers, diagnostic codes etc. We expect such a dataset to contain many of the 
technical words from the health domain that may not appear in general-domain datasets, and 
as the size of MIMIC-III is sufficiently large, we should be able to extract meaningful vector 
representations for these words. As a first step, we have selected a subset of the tables and 
columns, and generated a new dataset where each selected cell together with the title of the 
corresponding column form a pseudo-sentence. As the next step, we have used this dataset to 
 
re-train GloVe, and concatenated these specialized word embeddings with the others to create 
vectors that contain information from both approaches. Obviously, there are words that 
appear in the general dataset, but not in MIMIC-III, and the vice versa. In such cases, the 
corresponding embedding is still assigned randomly. If a word does not appear in either 
dataset, we assign its whole embedding randomly. In all cases, the embeddings are updated 
during training by the backpropagation step. 
 
B. Character-level embeddings 
Following Lample et al.5 we also add character-level embeddings of the words. Such 
embeddings reflect the actual sequence of characters of a word and have proven to be useful 
for specific-domain tasks and morphologically-rich languages. Typically, they contribute to 
catching prefixes and suffixes which are frequent in the domain, and correctly classifying the 
corresponding words. As an example, a word ending in “cycline” is very likely a drug name, 
and a character-level embedding could help classify it correctly even if the word was not 
present in the training vocabulary. All the characters are initialized with a random 
embedding, and then the embeddings are passed character-by-character to a dedicated LSTM 
in both forward and backward order. The final outputs in the respective directions promise to 
be useful encodings of the ending and the beginning of the word. These character-level 
embeddings are integral part of the LSTM architecture and are not available in the CRF or 
other models. The character embeddings, too, are updated during training with 
backpropagation. 
 
C. Feature Augmentation 
Conventional machine learning approaches for NER usually have a feature engineering 
step. Lee et al.24 have shown that adding hand-crafted features to a neural network can 
 
contribute to increase the recall. In our work, we try this approach with features similar to 
those used by Lee et al.24. Figure 3 shows the list of features used. 
 




A.  Datasets 
Hereafter, we evaluate the models on three datasets in the health domain. The first is the 
2010 i2b2/VA IRB Revision for CCE. This dataset is a reduced set of the original 2010 
i2b2/VA dataset that is no longer distributed due to restrictions introduced by the Institutional 
Review Board (IRB) in 2011.30 The other two datasets are DDI-DrugBank and DDI-
MedLine, both part of the SemEval-2013 Task 9.1 for DNR.31 Tables 1.a and Table 1.b 
describe the basic statistics of the datasets used in our experiments. We have used the official 
training and test sets released with the distributions for all the experiments. 
 
 Training set Test set 
Documents 170 256 
Sentences 16315 27626 
problem 7073 12592 
test 4608 9225 
treatment 4844 9344 
a) 2010 i2b2/VA IRB Revision 
 DDI-DrugBank DDI-MedLine 
Training set Test set Training set Test set 
Documents 730 54 175 58 
 
Sentences 6577 145 1627 520 
drug_n 124 6 520 115 
group 3832 65 234 90 
brand 1770 53 36 6 
drug 9715 180 1574 171 
b) SemEval-2013 Task 9.1 
Table 1. Statistics of the training and test datasets used in the experiments 
 
B.  Evaluation metrics 
We report the performance of the model in terms of the F1 score. The F1 score is a very 
relevant measure as it considers both the precision and the recall, computing a weighted 
average of them. If we note as TP the number of true positives, FP the false positives and FN 
the false negatives, we have: 
 













However, it must be remarked that there are different ways of computing the precision and 
the recall, depending on what we consider as a correct or incorrect prediction.32 In this work, 
we employ the “strict” evaluation method, where both the entity class and its exact 
boundaries are expected to be correct. We have used the B-I-O tagging standard to annotate 
the text at word level. In detail, ‘B’ means the beginning (first word) of a named entity; ‘I’ 
stands for ‘inside’, meaning that the word is part of the same entity (for multi-word entities; 
e.g., “albuterol sulfate”); and ‘O’ stands for ‘outside’, meaning that the word is not part of 
any named entities. Therefore, a valid annotation of a named entity always begins with a ‘B’. 
An example is shown in Figure 3. All the models used in this paper have been trained to 
predict explicit ‘B’ and ‘I’ labels for each entity class. The evaluation includes a pre-
processing step that converts an ‘I’ prediction to a ‘B’ if it follows directly an ‘O’ prediction, 
 
thus making all predicted entities valid. An entity is considered as correctly predicted only if 
all its ‘B’ and ‘I’ labels and all its classes are predicted correctly. As an example, in Figure 3 
the prediction will be counted as a true positive only if all the four words “recently diagnosed 
abdominal carcinomatosis” are tagged as a single entity of the problem class. Every differing 
‘B’ prediction will instead be counted as a false positive. The evaluation protocol explicitly 
counts only the true positives and the false positives, and derives the false negatives as 
(number of true entities – true positives). 
 
 
Figure 4. a) An example of an incorrect tagging in the “strict” evaluation method. b) An example of a correct tagging in the 
“strict” evaluation method 
 
C.  Training and hyperparameters 
For an unbiased evaluation, all the trained models have been tested blindly on unseen test 
data. In order to facilitate replication of the empirical results, we have used a publicly-
available library for the implementation of the neural networks (i.e. the Theano neural 
network toolkit33) and we release our code.34 To operate, any machine learning model 
requires both a set of parameters, which are learned automatically during training, and some 
“hyper-parameters”, which have to be selected manually. Therefore, we have divided the 
training set of each dataset into two parts: a training set for learning the parameters (70%), 
and a validation set (30%) for selecting the best hyper-parameters.35 The hyper-parameters of 
the LSTM include the number of hidden nodes (for both LSTMs), (Hw, Hc) ∈ {25, 50, 100}, 
the word embedding dimension, dw ∈ {50, 100, 200, 300, 600}, and the character embedding 
dimension, dc ∈ {25, 50, 100}. Additional hyper-parameters include the learning rate and the 
drop-out rate, which were left to their default values of [0.01] and [0.5] respectively.36 All 
 
weights in the network and the words that do not have a pre-trained word embedding have 
been initialized randomly from the uniform distribution within range [-1, 1], and updated 
during training with backpropagation. The number of training “epochs” (i.e., iterations) was 
set to 100, selecting the epoch that obtained the best results on the validation set. The best 
model from the validation set was finally tested on the unseen, independent test set without 
any further tuning, and the corresponding accuracy reported in the tables. Table 2 shows all 
the hyper-parameters used for the experiments reported in the Results section. 
Hyper-parameter Value 
word embedding dim (dw) 
word LSTM hidden layer dim (Hw) 
char embedding dim (dc) 




concatenated hand-crafted features 
dim 









Table 2. The hyper-parameters used in the experiments 
D.  Results 
Tables 3.a and 3.b show the performance of the proposed RNNs and the state-of-the-art 
systems on the 2010 i2b2/VA IRB Revision dataset and the SemEval-2013 Task 9.1 datasets, 
respectively. On the 2010 i2b2/VA IRB Revision dataset (Table 3.a), the Bidirectional LSTM-
CRF (B-LSTM-CRF) with Common Crawl embeddings (cc) and character-level embeddings 
(char) as features has obtained the best results (83.35% F1 score). The model has 
outperformed all systems from the literature (top quadrant of Table 3.a) which are all based 
on conventional domain-specific feature engineering. It is important to note that deBruijin et 
al.4  had reported a higher accuracy on 2010 i2b2/VA (85.23% F1 score), but their model was 
trained and tested on the original version of the dataset which is no longer available due to 
the restrictions introduced by the Institutional Review Board. As for what specialized 
embeddings are concerned, Table 4 shows that the general-domain dataset Common Crawl 
 
already contains almost all the words in the dataset. Therefore, adding the MIMIC-III 
embeddings (mimic) does not extend the vocabulary, and therefore it brings no improvement. 
On the other hand, in the Bidirectional LSTM model the (cc/mimic) embeddings give better 
results. As the baseline results of this model are lower, it may be happening that the bigger 
dimension of the concatenated embeddings is improving the previous results, even if we do 
not cover more vocabulary. Using conventional feature engineering instead of the word and 
character embeddings works worse (77.81% F1-score). Moreover, we do not see that 
concatenating features with the embeddings brings further improvement over the best model. 
Table 3.a also shows the importance of the final CRF layer in the B-LSTM-CRF, given that 
the B-LSTM alone was only able to achieve a 77.59% F1 score. In turn, the linear CRF has 
obtained a 64.09% F1 score in its best configuration, lower than any version of the LSTM. 
In the DNR task (Table 3.b) the B-LSTM-CRF with the concatenated word embeddings 
(cc/mimic) and the character-level embeddings (char) as features has improved over all the 
previous approaches on both DDI-DrugBank (88.38% F1 score) and DDI-MedLine (60.66% 
F1 score). Table 4 shows that only the 49% of the words in the datasets are found in the (cc) 
embeddings. However, when the concatenated embeddings (cc/mimic) are used, the 
percentage of words assigned to an embedding increases to 67% for DDI-DrugBank and 61% 
for DDI-MedLine, leading to better results in the classification task. Words that appear in the 
MIMIC-III dataset but are not contained in Common Crawl are very technical and domain-
specific such as drug names or treatments. Some examples are: pentostatin, sitagliptin, 
hydrobromide, organophosphate, pyhisiological, methimazole etc. In total, 1189 extra words 
have been mapped in DDI-DrugBank and 716 in DDI-MedLine thanks to the use of MIMIC-
III. Therefore, the use of a domain-specific dataset has proved significantly helpful in the 
Drug Name Recognition task. On the other hand, the Bidirectional LSTM model does not 
obtain any improvement in the DrugBank dataset while in the MedLine dataset it does. In the 
 
former, the results obtained by the previous model are already very high (84.35% F1-score) 
and difficult to improve. But on the contrary, it seems that the output CRF layer of the B-
LSTM-CRF can be more accurate when more vocabulary is covered with the (cc/mimic) 
embeddings. In the latter, the results of the previous model are very low (44.33%), and 
therefore, easy to improve. 
At its turn, as it happened with the CCE datasets, the hand-crafted features have a worse 
performance than the embeddings. We observe that the features work better in the DrugBank 
dataset, where it outperforms the (cc) general domain embeddings.  We attribute this 
phenomenon to the high number of drug labels in the dataset, which are simpler to predict. 
Again as it happened in CCE, the concatenation of the features and the embeddings have not 
improved the best results. As for the CCE task, the B-LSTM-CRF model has proved better 
than the B-LSTM alone which has only achieved 84.35% F1 score on DDI-DrugBank and 
45.92% on DDI-MedLine. Finally, we can see that the use of the character-level embeddings 
has led to higher relative improvements for the DDI-DrugBank dataset than the the other two 
datasets. A plausible explanation for this is that this dataset contains more words with 
distinctive prefixes and suffixes which are more effectively captured by character-level 
embeddings. 
In general, the CRF has significantly underperformed compared to the neural networks. 
We speculate that this model may require more extensive feature engineering to achieve a 
comparable performance, or that it may not be able to achieve it at all. In particular, we see 
that the CRF has performed the worst with DDI-MedLine. A possible explanation can be 
found in the “curse of dimensionality”: DDI-MedLine is a small dataset (1627 training 
sentences), while the overall dimensionality of the input embeddings is 746. This makes the 
learning problem very sparse and seems to seriously affect a linear model such as the CRF. 
 
On the contrary, the non-linear internal architecture of the neural networks may in some cases 
help reduce the effective dimensionality and mollify this problem. 
 
Model 
2010 i2b2/VA IRB Revision 
F1 score (%) 
Binarized Neural Embedding CRF17 82.80 
CliNER14 80.00 
Truecasing CRFSuite37 75.86 
CRF 11.27 
CRF + (features) 25.53 
CRF + (cc) 53.72 
CRF + (cc/mimic)  58.28 
CRF + (cc/mimic) + (features) 64.09 
B-LSTM 65.43 
B-LSTM + (features) 69.42 
B-LSTM + (cc) 75.17 
B-LSTM + (cc) + (char) 76.79 
B-LSTM + (cc/mimic) + (char) 77.19 
B-LSTM + (cc/mimic) + (char) + (features) 77.59 
B-LSTM-CRF 75.05 
B-LSTM-CRF + (features) 77.81 
B-LSTM-CRF + (cc) 82.85 
B-LSTM-CRF + (cc) + (char) 83.35 
B-LSTM-CRF + (cc/mimic) + (char) 82.70 
B-LSTM-CRF + (cc/mimic) + (char) + (features) 83.29 






F1 score (%) F1 score (%) 
WBI-NER3 87.80 58.10 
Hybrid-DDI2 80.00 37.00 
Word2Vec+DINTO1 75.00 57.00 
CRF 28.70 13.65 
CRF + (features) 44.52 20.19 
CRF + (cc) 43.42 32.62 
CRF + (cc/mimic)  53.12 30.87 
CRF + (cc/mimic) + (features) 66.45 29.36 
B-LSTM 65.09 21.28 
B-LSTM + (features) 75.43 30.88 
B-LSTM + (cc) 71.75 42.39 
B-LSTM + (cc) + (char) 84.35 43.33 
B-LSTM + (cc/mimic) + (char) 83.63 44.39 
B-LSTM + (cc/mimic) + (char) + (features) 84.06 45.92 
B-LSTM-CRF 69.50 44.60 
B-LSTM-CRF + (features) 75.78 43.36 
B-LSTM-CRF + (cc) 79.03 57.87 
B-LSTM-CRF + (cc) + (char) 87.87 59.02 
B-LSTM-CRF + (cc/mimic) + (char) 88.38 60.66 
B-LSTM-CRF + (cc/mimic) + (char) + (features) 87.42 59.75 
b) DNR results over the SemEval-2013 Task 9.1 
Table 3. Comparison of the results between the different RNN models and the state-of-the-art systems over the CNE and 
DNR tasks 
 Common Crawl 
(cc) 
Common Crawl + MIMIC-III 
(cc/mimic) 
2010 i2b2/VA IRB reviewed 99.99 % 99.99 % 
DDI-DrugBank 49.50 % 67.02 % 
DDI-MedLine 49.10 % 61.51 % 
 




2010 i2b2/VA IRB Revision 
Precision Recall F1 score 
 
B-LSTM-CRF+(cc)+(char) 
problem 81.29 83.62 82.44 
test 84.74 85.01 84.87 
treatment 83.36 83.55 83.46 




Precision Recall F1 score Precision Recall F1 score 
 
B-LSTM-CRF+(cc/mimic)+(char) 
group 81.69 87.88 84.67 69.14 60.22 64.37 
drug 94.77 89.56 91.83 73.89 77.33 75.57 
brand 84.21 90.57 87.27 100.00 16.67 28.57 
drug_n 00.00 00.00 00.00 68.18 25.57 37.19 
b) SemEval-2013 Task 9.1 
Table 5. Results by entity for the Bidirectional LSTM-CRF with character and Glove+Mimic-III embeddings 
 
 
Tables 5.a and 5.b break down the results by entity for the best model on each dataset. In 
the DDI-MedLine dataset, we can notice the poor performance at detecting brand. In DDI-
DrugBank, the same issue occurs with entity class drug_n. This issue, which is also shared by 
the other DNR systems, is likely attributable to the small sample size. Instead, in the 2010 
i2b2/VA IRB Revision dataset all entity classes are detected with similar F1 scores, likely 
owing to the larger number of samples per class. However, we see that brand achieves the 
second best F1-score in DDI-DrugBank despite its relatively low frequency in the dataset, 
and that drug_n obtains a very poor performance in DDI-MedLine even if it has the second 
highest frequency in the dataset. We identify two other main factors that may have a major 
impact on the accuracy: 1) the average length of the entities in each class, and 2) the number 
of test entities that had not been seen during the training stage. In this respect, the brand and 
drug entities are usually very short (average ~1 word), while the group and drug_n entities 
often have multiple words. As shorter entities are easier to predict correctly, brand obtains 
better accuracy than group in DDI-DrugBank. On the other hand, the drug_n and group 
entities have similar length, but in DDI-MedLine drug_n obtains a very poor performance, 
most likely because no entity of type drug_n that appears in the test set had been seen during 
training. Conversely, a large percentage of the test group entities had been seen during 
training and have therefore proved easier to predict. 
 
VI. CONCLUSION 
In this paper, we have set to investigate the effectiveness of the Bidirectional LSTM and 
Bidirectional LSTM-CRF – two specific architectures of recurrent neural networks – for drug 
name recognition and clinical concept extraction, and compared them with a baseline CRF 
model. As input features, we have applied combinations of different word embeddings 
(Common Crawl and MIMIC–III), character-level embedding and conventional feature 
 
engineering. We have showed that the neural network models have obtained significantly 
better results than the CRF, and reported state-of-the-art results over the 2010 i2b2/VA IRB 
Revision, DDI-DrugBank and DDI-MedLine datasets using the B-LSTM-CRF model. We 
have also provided evidence that retraining GloVe on a domain-specific dataset such as 
MIMIC-III can help learn vector representations for domain-specific words and increase the 
classification accuracy. Finally, we have showed that adding hand-crafted features does not 
further improve performance since the neural networks can learn useful word representations 
automatically from pre-trained word embeddings. Consequently, time-consuming, domain-
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